Showing results (211-220 of 651) with videos related to
Sort By:
Pageof 66
Diabetologia|May 16, 2020
Correction to: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD)John B Buse, Deborah J Wexler, Apostolos Tsapas, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 2, 2020
Prognostic Value of Early Systolic Lengthening by Strain Imaging in Type 2 DiabetesPhilip Brainin, Tor Biering-Sørensen, Magnus T Jensen, et al.European Journal of Endocrinology|December 23, 2025
Pharmacodynamics of vicadrostat for aldosterone synthase inhibition in patients with CKDIsabella A Gashaw, Katherine R Tuttle, Manuel Monroy Kuhn, et al.Diabetes & Metabolism|June 24, 2024
Association of multiple sclerosis with incident diabetes: A nationwide cohort studyJeppe Ravn Jacobsen, Søren L Kristensen, Emil L Fosbøl, et al.Frontiers in Epidemiology|March 8, 2024
Blood oxygen saturation is lower in persons with pre-diabetes and screen-detected diabetes compared with non-diabetic individuals: A population-based study of the Lolland-Falster Health Study cohortJens Christian Laursen, Randi Jepsen, Neda Esmailzadeh Bruun-Rasmussen, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 10, 2011
Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trialLian Engelen, Frederik Persson, Isabel Ferreira, et al.Journal of the American Heart Association|September 21, 2020
Carotid-Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes MellitusNinna Hahn Tougaard, Simone Theilade, Signe Abitz Winther, et al.Journal of Diabetes and Its Complications|May 3, 2017
Effect of weight reductions on estimated kidney function: Post-hoc analysis of two randomized trialsBernt Johan von Scholten, Melanie J Davies, Frederik Persson, et al.Diabetes, Obesity & Metabolism|May 21, 2025
Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney diseaseVictor Wasehuus, J David Smeijer, Phil Ambery, et al.Endocrine|February 5, 2013
Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general populationTea Skaaby, Lise Lotte Nystrup Husemoen, Charlotta Pisinger, et al.Pageof 66